Antimalarial Hydroxychloroquine May Reduce the Risk of Hyperlipidemia in Patients with Early Rheumatoid Arthritis
News, rheumatoid arthritis
According to a recent retrospective study by researchers at the Brigham and Women’s Hospital, Boston, in patients with early rheumatoid arthritis (RA), treatment with antimalarial hydroxychloroquine may reduce the risk ... Read more